| 注册
首页|期刊导航|临床神经外科杂志|miR-155在胶质瘤干细胞样细胞的表达及临床意义

miR-155在胶质瘤干细胞样细胞的表达及临床意义

王瑞彤 闫昕 陈辉 赵明明 王淑为 刘爽 尹丰

临床神经外科杂志2019,Vol.16Issue(4):278-282,5.
临床神经外科杂志2019,Vol.16Issue(4):278-282,5.DOI:10.3969/j.issn.1672-7770.2019.04.001

miR-155在胶质瘤干细胞样细胞的表达及临床意义

The expression of miR-155 in GSCs and its clinical significance

王瑞彤 1闫昕 2陈辉 2赵明明 3王淑为 3刘爽 3尹丰2

作者信息

  • 1. 100039 北京,航天中心医院神经内科
  • 2. 100039 北京,航天中心医院神经外科
  • 3. 海军总医院神经外科
  • 折叠

摘要

Abstract

To study the different expression of miR-155 in glioblastoma stem-like cells(GSCs), neural stem cells ( NSCs) and different grades glioma.To clarify the relationship of miR-155 expression, degree of malignancy and prognosis of glioma patients.Methods GSCs and NSCs were isolated in vitro using neurosphere culture , then characteristics of the GSCs and NSCs were identified by experiments of immunoflurescence and xenograft.QRT PCR technology was used to detect the expression levels of miR-155 in GSCs, NSCs, gliomas of different grades and normal brain tissues.Kaplan-meier survival curve analysis was performed in combination with patient prognosis.Results The expression of miR-155 increased significantly in GSCs compared with NSCs (P<0.05), and also increased with the malignant degree of glioma.The expression level of miR-155 in malignant glioma ( WHO Ⅲ,Ⅳ) was obviously higher than that of normal brain tissue (all P<0.05).The high expression of miR-155 was closely related to the poor prognosis of glioma. Conclusion The expression of miR-155 elevates in GSCs and malignant glioma specimens , and can be considered as biomarker for diagnosis and prognosis judgment of glioma.

关键词

miR-155/胶质瘤/胶质瘤干细胞样细胞/神经干细胞/预后

Key words

miR-155/glioblastoma/glioblastoma stem-like cells/neural stem cells/prognosis of glioma

分类

医药卫生

引用本文复制引用

王瑞彤,闫昕,陈辉,赵明明,王淑为,刘爽,尹丰..miR-155在胶质瘤干细胞样细胞的表达及临床意义[J].临床神经外科杂志,2019,16(4):278-282,5.

基金项目

国家自然科学基金(81172384) (81172384)

临床神经外科杂志

OACSTPCD

1672-7770

访问量3
|
下载量0
段落导航相关论文